- Home
- ECAT
as 03-28-2025 4:00pm EST
BlackRock ESG Capital Allocation Trust is a non-diversified, closed-ended management investment company. The Trust's investment objectives are to provide total return and income through a combination of current income, current gains, and long-term capital appreciation.
| Founded: | 2021 | Country: | United States |
| Employees: | N/A | City: | N/A |
| Market Cap: | 1.7B | IPO Year: | N/A |
| Target Price: | N/A | AVG Volume (30 days): | 278.6K |
| Analyst Decision: | N/A | Number of Analysts: | N/A |
| Dividend Yield: | Dividend Payout Frequency: | Monthly | |
| EPS: | 2.39 | EPS Growth: | N/A |
| 52 Week Low/High: | $14.02 - $17.30 | Next Earning Date: | 01-01-0001 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Stock Insider Trading Activity of BlackRock ESG Capital Allocation Term Trust of Beneficial Interest (ECAT)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| BlackRock, Inc. | ECAT | N/A | Mar 24 '25 | Buy | $16.34 | 46,745 | $763,813.30 | 1,223,545 | |
| BlackRock, Inc. | ECAT | N/A | Mar 21 '25 | Buy | $16.20 | 101,600 | $1,645,920.00 | 1,223,545 | |
| BlackRock, Inc. | ECAT | N/A | Mar 20 '25 | Buy | $16.31 | 101,600 | $1,657,096.00 | 1,223,545 | |
| BlackRock, Inc. | ECAT | N/A | Mar 19 '25 | Buy | $16.21 | 101,600 | $1,646,936.00 | 1,223,545 | |
| BlackRock, Inc. | ECAT | N/A | Mar 17 '25 | Buy | $16.18 | 101,600 | $1,643,888.00 | 1,223,545 | |
| BlackRock, Inc. | ECAT | N/A | Mar 14 '25 | Buy | $16.16 | 86,000 | $1,389,760.00 | 1,223,545 | |
| BlackRock, Inc. | ECAT | N/A | Mar 13 '25 | Buy | $16.41 | 86,000 | $1,411,260.00 | 1,223,545 | |
| BlackRock, Inc. | ECAT | N/A | Mar 12 '25 | Buy | $16.43 | 86,000 | $1,412,980.00 | 1,223,545 | |
| BlackRock, Inc. | ECAT | N/A | Mar 11 '25 | Buy | $16.24 | 86,000 | $1,396,640.00 | 1,223,545 | |
| BlackRock, Inc. | ECAT | N/A | Mar 10 '25 | Buy | $16.38 | 86,000 | $1,408,680.00 | 1,223,545 |
Latest BlackRock ESG Capital Allocation Term Trust of Beneficial Interest News
ECAT Breaking Stock News: Dive into ECAT Ticker-Specific Updates for Smart Investing
Business Wire
7 months ago
Distribution Dates and Amounts Announced for ECAT, BCAT, BMEZ, BSTZ and BIGZ
Business Wire
7 months ago
Certain BlackRock Funds Announce Final Results of Tender Offers
Business Wire
7 months ago
Certain BlackRock Funds Announce Expiration and Preliminary Results of Tender Offers
Business Wire
9 months ago
Saba Capital Corrects BlackRock’s Intentionally False and Misleading 2024 Annual Meeting Results
Business Wire
9 months ago
U.S. Court of Appeals for the Second Circuit Reaffirms Ruling That Certain Closed-End Funds, Including Funds Advised by BlackRock, Violated the Investment Company Act of 1940
Business Wire
9 months ago
U.S. District Court for the Southern District of New York Denies BlackRock’s Motion to Dismiss Saba Capital’s Entrenchment Bylaw Lawsuit
Business Wire
9 months ago
ISS Recommends Shareholders Vote the GOLD Proxy Card "FOR" Saba Capital’s Nominees at Four Major BlackRock Closed-End Funds
Business Wire
10 months ago
ISS Endorses ALL of Saba Capital’s Nominees at the BlackRock Science and Technology Term Trust and BlackRock California Municipal Income Trust
Compare ECAT vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "ECAT BlackRock ESG Capital Allocation Term Trust of Beneficial Interest - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.